Atlas FDA

MYNX ACE VASCULAR CLOSURE DEVICE (MYNX ACE )

FDA premarket approval P040044/S070 · decided 2016-03-10

Approval details

PMA number
P040044
Supplement
S070
Supplement type
Real-Time Process
Supplement reason
Change Design/Components/Specifications/Material
Trade name
MYNX ACE VASCULAR CLOSURE DEVICE (MYNX ACE )
Generic name
Device, hemostasis, vascular
Applicant
Cordis US Corporation
Date received
2016-01-07
Decision date
2016-03-10
Days to decision
63 days
Decision code
APPR
Product code
MGB
Advisory committee
Cardiovascular
Expedited review
No
Location
Miami Lakes, FL
Statement
Approval for an extension of the Mynx Ace Vascular Closure Device shelf life to 18 months.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.